We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,672 hedge funds and large institutions have $321B invested in Johnson & Johnson in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,619 increasing their positions, 1,536 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

45% more funds holding in top 10

Funds holding in top 10: 532773 (+241)

33% more call options, than puts

Call options by funds: $3.35B | Put options by funds: $2.52B

5% more repeat investments, than reductions

Existing positions increased: 1,619 | Existing positions reduced: 1,536

0.04% less ownership

Funds ownership: 69.15%69.11% (-0.04%)

0% less funds holding

Funds holding: 3,6773,672 (-5)

12% less capital invested

Capital invested by funds: $365B → $321B (-$44.1B)

Holders
3,672
Holders Change
-5
Holders Change %
-0.14%
% of All Funds
61.85%
Holding in Top 10
773
Holding in Top 10 Change
+241
Holding in Top 10 Change %
+45.3%
% of All Funds
13.02%
New
131
Increased
1,619
Reduced
1,536
Closed
88
Calls
$3.35B
Puts
$2.52B
Net Calls
+$833M
Net Calls Change
-$135M
Name Holding Trade Value Shares
Change
Change in
Stake
LFG
401
Lazard Frères Gestion
France
$42.7M -$2.3M -12,887 -5%
NRS
402
Neville Rodie & Shaw
New York
$42.5M -$414K -2,321 -1%
FLII
403
First Long Island Investors
New York
$42M -$1.9M -10,670 -4%
FHA
404
First Horizon Advisors
Tennessee
$41.8M +$14.8M +82,890 +54%
X
405
Xponance
Pennsylvania
$41.7M -$811K -4,554 -2%
CI
406
Conning Inc
Connecticut
$41.7M -$3.05M -17,129 -7%
RMA
407
Roffman Miller Associates
Pennsylvania
$41.3M -$615K -3,451 -1%
LCS
408
Levin Capital Strategies
New York
$41.2M -$1.29M -7,219 -3%
WB
409
WesBanco Bank
West Virginia
$41.1M -$985K -5,531 -2%
AIM
410
Achmea Investment Management
Netherlands
$40.5M -$863K -4,846 -2%
RC
411
RBO & Co
California
$40.5M +$32.8K +184 +0.1%
CTA
412
Chesley Taft & Associates
Illinois
$40.3M -$94.4K -530 -0.2%
HIC
413
Harvey Investment Company
Kentucky
$40.2M -$173K -973 -0.4%
NIM
414
Northeast Investment Management
Massachusetts
$40.1M +$205K +1,152 +0.5%
EWM
415
Evercore Wealth Management
New York
$40M -$13.1M -73,552 -25%
WFMPM
416
Woodley Farra Manion Portfolio Management
Indiana
$39.6M +$593K +3,329 +2%
BPCE
417
Bank Pictet & Cie (Europe)
Germany
$39.5M +$1.84M +10,348 +5%
GW
418
GW & Wade
Massachusetts
$39.3M +$2.63M +14,733 +7%
CG
419
Colony Group
Massachusetts
$39.2M +$4.25M +23,832 +12%
MIS
420
Morningstar Investment Services
Illinois
$39.1M +$1.55M +8,701 +4%
BHIA
421
Birch Hill Investment Advisors
Massachusetts
$38.8M -$324K -1,820 -0.8%
JIC
422
Johnson Investment Counsel
Ohio
$38.5M +$748K +4,197 +2%
MPWT
423
MassMutual Private Wealth & Trust
Connecticut
$38.4M +$1.13M +6,328 +3%
Voloridge Investment Management
424
Voloridge Investment Management
Florida
$38.3M +$27M +151,815 +237%
SI
425
Stephens Inc
Arkansas
$38.3M -$58.4K -328 -0.2%

JNJ Hedge Fund Activity: Q2 2022 in Review

3,672 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2022, worth a combined $321B — down 12% from $365B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new JNJ positions and 88 closed out — a net gain of 43 holders — while 1,619 added to existing stakes and 1,536 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.12B. The largest seller was Arrowstreet Capital, cutting an estimated $1.18B.

  • 3,672 institutional investors held Johnson & Johnson (JNJ) as of Q2 2022, down from 3,677 in Q1 2022.
  • Funds reported $321B of Johnson & Johnson stock for Q2 2022, down 12% quarter-over-quarter.
  • 131 funds opened new Johnson & Johnson positions in Q2 2022 and 88 closed out, a net change of +43 holders.
  • The largest Johnson & Johnson buyer in Q2 2022 was Morgan Stanley, an estimated $2.12B added.
  • The largest Johnson & Johnson seller in Q2 2022 was Arrowstreet Capital, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2022.